Promoting life-changing research is our mission

Scientists at the University of Geneva and the CHUV (Lausanne University Hospital) have discovered that a certain set of immune cells, long considered merely auxiliary, can be reprogrammed to directly attack cancer cells. This promising breakthrough paves the way for faster and more effective personalized treatments, including for pediatric cancers.

The ISREC Foundation is proud to fund this important project, conducted jointly by Prof. Camilla Jandus, Francesco Ceppi – MD PD MERc, and Prof. George Coukos at the University of Geneva and the CHUV, the aim being to strengthen immunotherapies in the fight against cancer.

Our commitment to supporting translational research, which bridges the gap between the lab and the patient’s bedside, is fully reflected in this work.

Congratulations to the teams involved in this project, and many thanks to all who contribute to these developments! For more information: Cancer: «forgotten» cells go on the offensive – Medias – UNIGE